Dr. Reddy's Subsidiary Receives Final Penalty Decision from Russian Tax Authority
Dr. Reddy's Laboratories Limited announced that its subsidiary, Dr. Reddy's Laboratories LLC, Russia, received a final penalty decision from the Interdistrict Inspectorate of the Federal Tax Service of Russia. The decision was received on April 13, 2026.The penalty relates to the levy of Value Added Tax (VAT) upon the re-classification of marketing services by the Tax Authority.
The details of the tax authority action are summarized below:
| Parameter | Details |
|---|---|
| Authority | Interdistrict Inspectorate of the Federal Tax Service of Russia (Tax Authority) |
| Date of Decision Receipt | April 13, 2026 |
| Violation Committed | Levy of Value Added Tax (VAT) upon re-classification of marketing services |
| Financial Implication | The Tax Authority quantified a penalty of RUB 9.27 million (INR 11.40 million). This penalty amount is against an original quantified amount of RUB 20.09 million (INR 24.50 million). |
Following the receipt of the final penalty decision, the company stated that, based on its evaluation, the stated penalty amount has no material impact on the financials, operations, or other activities of the Company.
DRREDDY Stock Price Movement
On Monday, Dr. Reddy's Laboratories Limited shares edged higher to close at ₹1235.9, completing the session with a gain of 0.17% on ₹2.10. The stock found support from trading activity throughout the day, seeing a total volume of 1.46 million shares change hands.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.